Dr Noor Hisham: Health Ministry has begun Ivermectin trial for high-risk Covid-19 patients


KUALA LUMPUR (Bernama): The Health Ministry and the Institute for Clinical Research (ICR) have started clinical trials to study the use and efficacy of Ivermectin for high-risk Covid-19 patients at 12 of the ministry's hospitals.

Health director-general Tan Sri Dr Noor Hisham Abdullah said Ivermectin is a Food and Drug Administration (FDA) approved anti-parasitic drug widely used for treating several neglected tropical diseases, including onchocerciasis, strongyloidiasis and helminthiases, however, the evidence is inconclusive to recommend routine use of Ivermectin for Covid-19 patients.

Subscribe now for a chance to win your dream holiday!

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Nation

Senator apologises for illegally parking, says ready to be compounded
Senior citizen conveys gratitude to Penampang OCPD personally for rescue during floods
Stricter enforcement needed to combat rising cybercrime, says analyst
National Unity Ministry prepared to collaborate on 3R legislation, says deputy minister
Car, three motorcycles razed in fire at Kg Baru PKNS flats
Ten charged in KK over RM24.2mil bank fraud
Five crunchy facts about 'kacang putih'
Private hospital group backs Bank Negara's move for medical insurance co-payments
Goreng pisang vendor suspected of abducting two girls brought to court
Tech-savvy Melaka teen publishes book of tips for competitive programming

Others Also Read